Nicorandil reduces risk of major coronary events in patients with angina

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1316, 2001-01, pp. : 11-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nicorandil: A Review of its Use in the Management of Stable Angina Pectoris, Including High-Risk Patients

By Simpson Dene Wellington Keri

Drugs, Vol. 64, Iss. 17, 2004-01 ,pp. : 1941-1955

Adis International

Access to resources Recommend Favorite

Ranolazine dose not reduce the risk of major cardiovascular events in patients with acute coronary syndromes

Inpharma, Vol. 1, Iss. 1586, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Add-On Benefit to Coronary Artery Bypass Grafting of Treatment with Ramipril for Major Cardiac Events and Left Ventricular Remodeling in Intermediate-Risk Patients

Heart Drug, Vol. 3, Iss. 2, 2003-08 ,pp. : 73-81

Karger

Access to resources Recommend Favorite

Long-term administration of pravastatin reduces the risk of stroke in patients with coronary disorders

Inpharma, Vol. 1, Iss. 1277, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Nicorandil beneficial in chronic stable angina

Inpharma, Vol. 1, Iss. 1334, 2002-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite